Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty | Zendy

Sandy A. van Gool | Zendy; Gerdine A. Kamp | Zendy; Hanneke Visservan Balen | Zendy; Dick Mul | Zendy; J. J. J. Waelkens | Zendy; M. Jansen | Zendy; Liesbeth Verhoeven-Wind | Zendy; Henriëtte A. Delemarrevan de Waal | Zendy; Sabine M.P.F. de Muinck KeizerSchrama | Zendy; Geraline L. Leusink | Zendy; Jan C. Roos | Zendy; Jan M. Wit | Zendy

Open Access

Final Height Outcome after Three Years of Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Short Adolescents with Relatively Early Puberty

Author(s) -

Sandy A. van Gool,

Gerdine A. Kamp,

Hanneke Visservan Balen,

Dick Mul,

J. J. J. Waelkens,

M. Jansen,

Liesbeth Verhoeven-Wind,

Henriëtte A. Delemarrevan de Waal,

Sabine M.P.F. de Muinck KeizerSchrama,

Geraline L. Leusink,

Jan C. Roos,

Jan M. Wit

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2272

Subject(s) - medicine , bone mineral , gonadotropin releasing hormone agonist , endocrinology , bone age , short stature , regimen , body mass index , bone density , agonist , growth hormone treatment , hormone , gonadotropin releasing hormone , growth hormone , osteoporosis , luteinizing hormone , receptor

Our objective was to assess final height (FH) and adverse effects of combined GH and GnRH agonist (GnRHa) treatment in short adolescents born small for gestational age or with normal birth size (idiopathic short stature).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research